Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism SIRT5 inhibitors(NAD-dependent protein deacetylase sirtuin-5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H32ClN7O3S |
InChIKeyYVUGRSDTNXBWNT-FQEVSTJZSA-N |
CAS Registry2951090-00-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Kidney Injury | Preclinical | CN | 09 Aug 2023 |